Ono Pharmaceutical Co., Ltd. (OPHLY)
5.09
-0.02
(-0.39%)
USD |
OTCM |
Aug 24, 16:00
Ono Pharmaceutical EPS Diluted (Quarterly) : 0.1075 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1075 |
| March 31, 2026 | 0.0036 |
| December 31, 2025 | 0.1329 |
| September 30, 2025 | 0.1079 |
| June 30, 2025 | 0.0866 |
| March 31, 2025 | -0.0305 |
| December 31, 2024 | 0.0696 |
| September 30, 2024 | 0.0801 |
| June 30, 2024 | 0.1128 |
| March 31, 2024 | 0.0829 |
| December 31, 2023 | 0.1708 |
| September 30, 2023 | 0.2033 |
| June 30, 2023 | 0.1579 |
| March 31, 2023 | 0.0879 |
| December 31, 2022 | 0.1608 |
| September 30, 2022 | 0.1622 |
| June 30, 2022 | 0.155 |
| March 31, 2022 | 0.0929 |
| December 31, 2021 | 0.1079 |
| September 30, 2021 | 0.1334 |
| June 30, 2021 | 0.1455 |
| March 31, 2021 | 0.0562 |
| December 31, 2020 | 0.1685 |
| September 30, 2020 | 0.1143 |
| June 30, 2020 | 0.1322 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0478 |
| December 31, 2019 | 0.1156 |
| September 30, 2019 | 0.1006 |
| June 30, 2019 | 0.0956 |
| March 31, 2019 | 0.049 |
| December 31, 2018 | 0.0813 |
| September 30, 2018 | 0.0784 |
| June 30, 2018 | 0.0896 |
| March 31, 2018 | 0.0524 |
| December 31, 2017 | 0.115 |
| September 30, 2017 | 0.0544 |
| June 30, 2017 | 0.0662 |
| March 31, 2017 | 0.073 |
| December 31, 2016 | 0.11 |
| September 30, 2016 | 0.0574 |
| June 30, 2016 | 0.0789 |
| March 31, 2016 | 0.0313 |
| December 31, 2015 | 0.0375 |
| September 30, 2015 | 0.0124 |
| June 30, 2015 | 0.0483 |
| March 31, 2015 | -0.0143 |
| December 31, 2014 | 0.0662 |
| September 30, 2014 | 0.0022 |
| June 30, 2014 | 0.0178 |
| March 31, 2014 | 0.0055 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Astellas Pharma, Inc. | 0.4955 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 151.63M |
| Revenue (Quarterly) | 728.94M |
| Total Expenses (Quarterly) | 577.39M |
| Enterprise Value | 6.571B |
| Gross Profit Margin (Quarterly) | 75.31% |
| Profit Margin (Quarterly) | 20.80% |
| Earnings Yield | 6.91% |